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previous study, we showed anti-invasiveness effect of brittle star
saponin. Lee et al in 2011 explored the anti metastatic properties
of polysaccharide from Asterinapectinifera against breast cancer
cells and demonstrated starfish polysaccharide as promising anti
tumor agent.
Conclusion: Consequently, the extracted polysaccharide from
brittle star, which exerted cytotoxicity on cervical cancer cells can
potentially prevent cervical cancer progression and migrations.
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Introduction: The important modality applied in appropriate
determination of cancer therapy is cell imaging. The current imaging
approaches used in cancer screening and diagnosis application have
been classified as x-ray, computed tomography, ultrasound, radionu-
clide imaging and MRI. However, major limitation associated with
current imaging techniques such as lack of sufficient sensitivity for
detecting small number of cancer cells in primary level of metastasis
and not appropriate efficient for determining cancer cell-surface
markers, demand improvement strategy in current imaging methods
and development of efficient imaging probes for highly sensitive and
specific detection. Furthermore, the unavailability of simple, quick
and sensitive cancer diagnostic techniques has become the main driv-
ing force for Quantum Dots (QDs), a new class of fluorescent probes
with fascinating optical electronic properties, to the era of bioimaging.
The unique optical properties of QDs compared with organic flu-
orescent compound such as rhodamine is the main reason for impres-
sive progress of QDs in in vivo cancer imaging filed. This review
focuses on the unique optical properties of QDs over organic dyes flu-
orophores. The most prominent properties of QDs were defined as
their large absorption coefficient across a wide spectral range, high
photostability and intense fluorescent emission and most importantly,
their size- and composition-tunable emission from visible to infrared
wavelengths. The light photostability of the emitted fluorescence over
several months guarantees the imaging repeatability and also sym-
metric and much narrow QD emission peak compared with rhod-
amine 6G, decreases peak interference and surely will increases the
reliability and accuracy of cell imaging. On the other hand, QDs
can be efficiently excited in a broad wavelength range which allows
more wavelengths for exciting the QDs-tags and thus routine wave-
length such as UV-light (330 nm) can excite QDs for emitting visible
light. Furthermore, these advantages provide exceptional conditions
for detecting several target cells without any emission interference
simultaneously by several kinds of QDs. The release of cadmium
ions can be considered as a disadvantage because this heavy metal
is toxic for living cell but their coating, by promoting stability, can
restrain the release of cadmium. The several studies in cell lines indi-
cated that cell growth under normal media did not affect by QDs.Due to their ideal properties, rapid development of QD-based
technology for Bioimaging is not
unexpected and following global efforts, nowadays numerous QD-
based imaging methods exist for addressing diagnostic issues. On the
other hand, the development of biomolecules conjugation area to dif-
ferent tags such as quantum dots, provide background for progressing
and promoting the QDs Biomarkers for targeting the tumor cells and
quantitative measurement of molecular targets.
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Introduction: Exosomes are naturally occurring membrane-
enclosed vesicles 30e100 nm in diameter that are produced under
both physiological and pathological conditions and by the most cell
type of hematopoietic and non hematopoietic origin, such as mast
cells, macrophages, antigen-presenting cells (APCs), B and T lym-
phocytes, platelets and dendritic cells (DCs) and tumor cells, as
well. Analyzing by electron microscopy, they usually show a “cup-
shaped” morphology.
Exosomes are recognized as mediators of cell-to-cell communica-
tion and involve specific proteins from endosomes, the plasma mem-
brane and the cytosol from the parental cells. Cellular origin of
exosomes is the main factor in determining their protein content
and enrichment of certain molecules such as targeting/adhesion mol-
ecules (e.g., lactadherin), membrane trafficking molecules (annexins),
cytoskeleton molecules (tubulin), chaperones (Hsp90) and cytoplas-
mic enzymes (GAPDH). The protein composition of exosomes is dif-
ferent in tumor cells compared to nonmalignant cells. These
structures have been isolated from various body fluids, including
semen, blood, urine, saliva, breast milk, amniotic fluid, ascites fluid,
cerebrospinal fluid and bile.
Tumor-derived exosomes (TDEs) containing tumor antigens,
immunosuppressive proteins and functional RNAs and they have plei-
otropic biological functions: I- The intercellular swapping of proteins
and genetic materials through exosomes play a significant role in cell-
to-cell communication and induce phenotypic changes within the
tumor microenvironment. The interaction between exosomes and tar-
get cells is mediated by surface-expressed bioactive lipids, growth
factors and membrane receptors. Exosomes contained mutated
mRNA transcripts and DNA fragments promote growth and prolifer-
ation of many primary and metastatic cancers. Besides, TDEs involve
distinct microRNA profiles in many cancers.
II-TDEs have been suggested as a new cancer vaccine. Possessing
tumor rejection antigen with elevated immunogenicity, exosomes
derived from IL-2 and IL-18 gene-modified tumor cells could induce
specific antitumor responses. So, these exosomes expressing cyto-
kines as adjuvants expose a modern strategy of exosomes-based vac-
cines. Using this strategy, it is possible to accommodate the adhesion
molecules, cytokines and chemokines into exosomes to obtain cancer
vaccines supplying sufficient immune responses in future trials.
III- recent studies definitely represent that some tumor cell lines
produce exosomes expressing death ligand such as functional FasL
and TRAIL which can induce the apoptotic pathways in the activated
T cells both in vitro and in vivo. Similarly, TDEs inhibit cytotoxic
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naling in vivo and in vitro.
IV- TDEs can also skew monocyte differentiation into DCs toward
the generation of myeloid derived suppressor cells and display Trans-
forming Growth Factor- b1 (TGF-b1) mediated suppressive activity
on T Lymphocytes in vitro. By eeleasing of vesicular structures,
tumor cells can adjust host environment for surviving and progressing
in vivo. Another supporting study in mouse models demonstrated that
exosomes secreted by murine mammary carcinoma cells and mela-
noma cells suppressed the differentiation of DCs via inducing IL-6.
V- TDEs can participate in drug resistance via several mecha-
nisms. The first mechanism is by drug exportation through the exo-
some pathway. Ovarian carcinoma cells stably got resistance to the
cancer chemotherapy drug cisplatin (CDDP). Exosomes snared cyto-
plasmic CDDP, and then exported it to exit the cell. To do it, multi-
vesicular bodies fuse with the plasma membrane and leave their
content. In addition, exosomes can nullify antibody-based drugs.
Exosomes produced by HER2-overexpressing breast carcinoma cell
lines that express a full-length HER2 molecule can bind to the
HER2 antibody Trastuzumab. Exosomal inhibition of antibody by
reducing antibody binding to cancer cells suppresses the effect of
Trastuzumab on the proliferation of these cells. On the other hand,
due to the similarity of Cl concentration within exosomes and
extracellular fluids, once chemotherapy agent Cisplatin incorporated
into exosomes secreted by melanoma cells, it remains in native unhy-
drated form.
VI- Exosomes can be used as biomarkers to monitor the emer-
gence, progression, prognosis of cancer, and efficacy of treatment
regimens. Exosomes can be detected in higher concentrations, both
in tumor tissue, and the serum and plasma of cancer patients.
VII- TDEs displacing a role in tumor progression and metastatic
niche formation as mediators of metastasis. They mobilize bone mar-
row-derived cells (BMDCs) that support tumor vasculogenesis, inva-
sion and metastasis. Furthermore, the presence of melanoma
exosomes in lymph nodes induces angiogenic growth factors neces-
sary for melanoma growth and metastasis even in the local absence
of tumor cells.
In summary, the unique character of exosomes, including their
ability to induce antitumor responses, express death ligand and
accommodate specific genetic materials, their participating in drug
resistance, their stability in circulation, their reproducible detection
and, significantly, the fact that they show the properties of cancer
cells, indicate they may be used as diagnostic strategies for non-inva-
sive and quick tracing of the pathological condition of cancer
patients, as well as therapeutic agents and cancer vaccine for provid-
ing viable treatment options.
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Extended Abstract
Introduction: MicroRNAs are a group of endogenous, non-cod-
ing RNAs which have ~22 nucleotides. MiRNAs inhibit mRNAexpression in posttranscriptional manner. MicroRNAs are known as
main regulatory molecules that control over half of the protein coding
genes in human.
MicroRNAs recognizing key cancer molecular regulators for tar-
get therapies may specifically eliminate tumor cells. On the other
hand, dysregulation of non-coding RNAs have been observed in var-
ious types of cancers. Recently, many miRNA based therapies are
growing up which specifically target cancerous cells. These
approaches are different based on the effects of miRNAs in tumor
cells. In the following, we will overview current strategies in the field
of miR therapy in cancers.
Therapeutic strategies with miRNAs:MiRNAs could be divided
into two categories depends on the oncogenic function or tumor sup-
pressor activity of them in the cells. MiRNA therapy techniques are
designed for blocking of oncomiRs or increasing the expression of
tumor suppressor miRNAs. So, miRNA-based therapies include
blocking miRNAs and restoring miRNAs.
Blocking miRNAs: Blocking miRNAs are designed for blocking
the function of oncomiRs.
Antisense oligonucleotides (ASOs): ASOs are single-stranded
chemically modified RNA molecules that are complementary with
target miRNAs. Antisense oligonucleotides based on the mechanism
of action are divided into two categories:
I) The RNase H-dependent oligonucleotides; in this manner crea-
tion of RNA/DNA duplex leads to the degradation of the target
mRNA.
II) The steric-blocker oligonucleotides; these oligonucleotides
only bind to the 5 or AUG initiation codon region and inhibit the pro-
duction of proteins.
In the following, some strategies of ASOs methods are introduced
briefly:
LNA anti-miRs
LNA anti-miRs are partially modified antisense oligonucleotides.
These molecules have 13-22 ribonucleotides. The methylene bridge
between 20 oxygen and 40 carbon causes greater target specificity
and great nuclease stability.
Tiny LNA anti-miRs
They are fully modified ASOs with 8 nucleotides that target miR-
NAs seed region. These molecules can be used for suppressing miR-
NAs with the same seed sequence and consequently increase
expression of related protein coding genes.
Antagomirs
Antagomirs are single-stranded RNAs which are conjugated with
cholesterol. They have 23 ribonucleotides with 20 O methoxyethyl
group modification and partial phosphorothioate backbone. Conju-
gated cholesterol makes Antagomirs easily transfer to the cells. Anta-
gomirs complement to the whole sequence of mature target miRNAs,
so they are very specific.
miR sponges
Sponges contain multiple tandem repeat of certain miRNA seed
region that would be suppressed. These sequences are expressed under
strong promoters such as CMV promoter. miR sponges have a great
potential for targeting miRNA families with the same seed region.
Small molecule inhibitors (SMIRs)
SMIRs are chemical component that interfere with miRNAs, fur-
thermore they could be used as an important tools for identifying the
mechanism of miRNAs function and offering new therapeutic
approaches. For example, azobenzene acts as a specific inhibitory
molecule for miRNA-21. These molecules cause an increased chemo-
therapy response and also act as an anti-cancer drug. However, they
